Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

(2017) David Erlinge et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials

(2016) Shuo Zhang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies

(2016) Tilak Pasala et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial

(2016) Sergio Leonardi et al.   BMJ-British Medical Journal

Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial

(2016) Sergio Leonardi et al.   BMJ-British Medical Journal

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2015) Marco Roffi et al.   EUROPEAN HEART JOURNAL

Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

(2015) Yaling Han et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

(2015) Marco Valgimigli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

(2014) S. Schulz et al.   EUROPEAN HEART JOURNAL

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

(2014) Ezra A. Amsterdam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

(2014) Matthew A Cavender et al.   LANCET

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial

(2014) Adeel Shahzad et al.   LANCET

Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention

(2013) Adnan K. Chhatriwalla et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bivalirudin Started during Emergency Transport for Primary PCI

(2013) Philippe Gabriel Steg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty–Bivalirudin vs Heparin Study)

(2012) Giuseppe Patti et al.   AMERICAN JOURNAL OF CARDIOLOGY

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

(2012) et al.   CIRCULATION

Abciximab and Heparin versus Bivalirudin for Non–ST-Elevation Myocardial Infarction

(2011) Adnan Kastrati et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

(2008) Gjin Ndrepepa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bivalirudin during Primary PCI in Acute Myocardial Infarction

(2008) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE